Novus Biologicals
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
$60.0m Valuation: $60.0m | Acquisition | ||
Total Funding | - |
Recent News about Novus Biologicals
EditNovus Biologicals, LLC is a prominent supplier of high-quality antibodies and research reagents, catering primarily to the life science research community. The company operates in the biotechnology market, focusing on providing essential tools for scientific discovery. Novus Biologicals serves a diverse range of clients, including academic institutions, pharmaceutical companies, and research organizations. The business model revolves around developing, marketing, and selling unique biological products that support cutting-edge research. Revenue is generated through the direct sale of these specialized reagents and antibodies, which are crucial for various research applications such as disease studies, cellular mechanisms, and neurological illnesses. Novus Biologicals also emphasizes the commercialization of unique biological materials, ensuring that researchers have access to the latest tools and trends in the scientific community. The company is committed to accelerating scientific discovery by continually monitoring and adapting to emerging scientific trends. As part of Bio-Techne, Novus Biologicals benefits from a broader network and resources, enhancing its ability to serve the research community effectively.
Keywords: antibodies, research reagents, life sciences, biotechnology, scientific discovery, academic institutions, pharmaceutical companies, disease studies, cellular mechanisms, neurological research.